Dengue Vaccine Market Growing public awareness and support from both government and non-government agencies will drive the prospects for growth in dengue vaccine market during the forecast period 2018 to 2021
The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking. The scientific community hypothesizes that the DENV evolved in nonhuman primates from where it spread to humans first in Southeast Asia and Africa and then to other parts of the world.
Research analysts forecast the Global Dengue Vaccine Market to grow at a CAGR of 15.05% during the period 2017-2021.
Key vendors
- GlaxoSmithKline
- Merck Sharp & Dohme
- Sanofi
- Takeda Pharmaceuticals
Request for sample copy of this report at: http://orbisresearch.com/contacts/request-sample/1003621
Covered in this report
The report covers the present scenario and the growth prospects of the global dengue vaccine market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Research report, Global Dengue Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors
- GeneOne Life Sciences
- Medigen Biologics
- Panacea Biotec
- Sun Pharmaceutical
Market driver
- Rapid growth in disease prevalence
- For a full, detailed list, view our report
Market challenge
- Regulatory hurdles in vaccine penetration
- For a full, detailed list, view our report
Market trend
- Licensing deals
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Companies Mentioned:
GlaxoSmithKline, Merck Sharp & Dohme, Sanofi, and Takeda Pharmaceuticals, GeneOne Life Sciences, Medigen Biologics, Panacea Biotec, and Sun Pharmaceutical.
Enquire more details of the report at: http://orbisresearch.com/contact/purchase/1003621
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello, Senior Manager – Client Engagements
Email: Send Email
Phone: +1 (214) 884-6817; +9164101019
Address:4144N Central Expressway, Suite 600
City: Dallas
State: Texas – 75204
Country: United States
Website: http://www.orbisresearch.com/reports/index/global-dengue-vaccine-market-2017-2021
Source: www.abnewswire.com
